Loading...
Loading...
India's lansoprazole imports from SOUTH KOREA total $143 across 1 shipments from 1 foreign suppliers. WHAN IN PAHRM CO., LTD leads with $143 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GENECHT RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for lansoprazole โ a concentrated sourcing relationship with select suppliers from SOUTH KOREA.

WHAN IN PAHRM CO., LTD is the leading Lansoprazole supplier from SOUTH KOREA to India, with import value of $143 across 1 shipments. The top 5 suppliers โ WHAN IN PAHRM CO., LTD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WHAN IN PAHRM CO., LTD | $143 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GENECHT RESEARCH PRIVATE LIMITED | $143 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Lansoprazole suppliers from SOUTH KOREA to India include WHAN IN PAHRM CO., LTD. The leading supplier is WHAN IN PAHRM CO., LTD with import value of $143 USD across 1 shipments. India imported Lansoprazole worth $143 USD from SOUTH KOREA in total across 1 shipments.
India imported Lansoprazole worth $143 USD from SOUTH KOREA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Lansoprazole sourced from SOUTH KOREA include GENECHT RESEARCH PRIVATE LIMITED. The largest buyer is GENECHT RESEARCH PRIVATE LIMITED with $143 in imports across 1 shipments.
The total value of Lansoprazole imports from SOUTH KOREA to India is $143 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists